Literature DB >> 19775623

Lung tumours with neuroendocrine differentiation.

William D Travis1.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19775623     DOI： 10.1016/S0959-8049(09)70040-1

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  37 in total

1.  MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase Inhibition.

Authors:  Gurkan Mollaoglu; Matthew R Guthrie; Stefanie Böhm; Johannes Brägelmann; Ismail Can; Paul M Ballieu; Annika Marx; Julie George; Christine Heinen; Milind D Chalishazar; Haixia Cheng; Abbie S Ireland; Kendall E Denning; Anandaroop Mukhopadhyay; Jeffery M Vahrenkamp; Kristofer C Berrett; Timothy L Mosbruger; Jun Wang; Jessica L Kohan; Mohamed E Salama; Benjamin L Witt; Martin Peifer; Roman K Thomas; Jason Gertz; Jane E Johnson; Adi F Gazdar; Robert J Wechsler-Reya; Martin L Sos; Trudy G Oliver
Journal:  Cancer Cell       Date:  2017-01-12       Impact factor: 31.743

2.  Primary Pulmonary Carcinoid Tumor: A Long-term Single Institution Experience.

Authors:  Ryan F Herde; Kristine E Kokeny; Chakravarthy B Reddy; Wallace L Akerley; Nan Hu; Jonathan P Boltax; Ying J Hitchcock
Journal:  Am J Clin Oncol       Date:  2018-01       Impact factor: 2.339

Review 3.  Mixed Neuroendocrine-Nonneuroendocrine Neoplasms (MiNENs): Unifying the Concept of a Heterogeneous Group of Neoplasms.

Authors:  Stefano La Rosa; Fausto Sessa; Silvia Uccella
Journal:  Endocr Pathol       Date:  2016-12       Impact factor: 3.943

Review 4.  Family matters: How MYC family oncogenes impact small cell lung cancer.

Authors:  Johannes Brägelmann; Stefanie Böhm; Matthew R Guthrie; Gurkan Mollaoglu; Trudy G Oliver; Martin L Sos
Journal:  Cell Cycle       Date:  2017-07-24       Impact factor: 4.534

5.  Evaluation of diagnostic and prognostic significance of Ki-67 index in pulmonary carcinoid tumours.

Authors:  V Clay; G Papaxoinis; B Sanderson; J W Valle; M Howell; A Lamarca; P Krysiak; P Bishop; D Nonaka; W Mansoor
Journal:  Clin Transl Oncol       Date:  2016-11-15       Impact factor: 3.405

Review 6.  Cardiothoracic manifestations of neuroendocrine tumours.

Authors:  Ramin Mandegaran; Sarojini David; Nicholas Screaton
Journal:  Br J Radiol       Date:  2016-01-19       Impact factor: 3.039

7.  Theranostic implications of molecular imaging phenotype of well-differentiated pulmonary carcinoid based on 68Ga-DOTATATE PET/CT and 18F-FDG PET/CT.

Authors:  Lamiaa Zidan; Amir Iravani; Grace Kong; Tim Akhurst; Michael Michael; Rodney J Hicks
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-06-22       Impact factor: 9.236

8.  Targeting transcriptional addictions in small cell lung cancer with a covalent CDK7 inhibitor.

Authors:  Camilla L Christensen; Nicholas Kwiatkowski; Brian J Abraham; Julian Carretero; Fatima Al-Shahrour; Tinghu Zhang; Edmond Chipumuro; Grit S Herter-Sprie; Esra A Akbay; Abigail Altabef; Jianming Zhang; Takeshi Shimamura; Marzia Capelletti; Jakob B Reibel; Jillian D Cavanaugh; Peng Gao; Yan Liu; Signe R Michaelsen; Hans S Poulsen; Amir R Aref; David A Barbie; James E Bradner; Rani E George; Nathanael S Gray; Richard A Young; Kwok-Kin Wong
Journal:  Cancer Cell       Date:  2014-12-08       Impact factor: 31.743

9.  Survival and Predictors of Death for Patients with Bronchopulmonary Carcinoid at a Danish Tertiary NET Centre.

Authors:  Linda Skibsted Kornerup; Gitte Dam; Henning Gronbaek
Journal:  In Vivo       Date:  2017 May-Jun       Impact factor: 2.155

Review 10.  Prognostic significance of neuroendocrine differentiation in colorectal adenocarcinoma after radical operation: a meta-analysis.

Authors:  Yu-Jie Zeng; Wei Lai; Lu Liu; Heng Wu; Xing-Xi Luo; Jie Wang; Zhong-Hua Chu
Journal:  J Gastrointest Surg       Date:  2014-02-19       Impact factor: 3.452
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.